Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy

Clinical trial NCT02403869 · COMPLETED

Trial details

NCT number: NCT02403869
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Neoplasms

Start date: 2014-03-12
Primary completion: 2019-01-31
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.